Anzeige
Mehr »
Sonntag, 30.08.2026 - Börsentäglich über 12.000 News
Breaking News: NurExone läutet die nächste Runde ein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Euronext

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
31.07.AXA - Half Year 2026 Earnings
31.07.NWMFRN11NOV26: NatWest Markets N.V. Interim Results 2026
31.07.Rebirth S.p.A.: REBIRTH - 2026 Half-Year Revenues in line with expansion plans
30.07.NRJ GROUP - Press release Half-Year Results 2026
30.07.EHI! lists on Euronext
30.07.AMA CORPORATION PLC: Second-quarter 2026 revenues
30.07.Availability of Atos Group's 2026 Half-Year Financial Report
29.07.BE Semiconductor Industries N.V. Announces Transactions Under Share Repurchase Program
29.07.ALTAREIT: Availability of the half-year financial report for 2026
29.07.ALTAREA: Availability of the half-year financial report for 2026
29.07.Elis: H1 2026 results
29.07.ALTAREIT: Press Release and Business Review 30 June 2026
29.07.ALTAREA: Press Release and Business Review 30 June 2026
29.07.ALTAREA: Half-year financial report 30 June 2026
29.07.ES VEDRA PROPERTIES SOCIMI: Merger by Absorption of the Company's Wholly Owned Subsidiary
29.07.EMBENTION SISTEMAS INTELIGENTES: Shareholder meeting minutes 30.06.2026
29.07.ES VEDRA PROPERTIES SOCIMI: Minutes of the Sole Shareholder: Approval of the Merger by Absorption
29.07.HIPAY GROUP: Half-Year Consolidated revenue as at June 30th 2026
28.07.AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2026
28.07.ALPES (COMPAGNIE): CDA acquires 33,9% in Padel City
28.07.INVIBES ADVERTISING N.V.: Invibes Advertising: H1 2026 Revenue.
28.07.ALPES (COMPAGNIE): CDA - Q3 sales 2025 2026
28.07.ACOMO N.V.: ACOMO REPORTS ROBUST H1 2026 WITH HEALTHY MARGIN AND PROMISING RECOVERY IN EDIBLE SEEDS US
27.07.VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge A milestone fully aligned with Valbiotis' mission
27.07.260727 BENETEAU Revenue H1 2026 EN